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Caspase activation in the terminal differentiation of human
epidermal keratinocytes
Miguel Weil*†‡, Martin C. Raff*† and Vania M.M. Braga*§
The epidermis is a multilayered squamous epithelium in
which dividing basal cells withdraw from the cell cycle
and progressively differentiate as they are displaced
toward the skin surface. Eventually, the cells lose their
nucleus and other organelles to become flattened
squames, which are finally shed from the surface as
bags of cross-linked keratin filaments enclosed in a
cornified envelope [1]. Although keratinocytes can
undergo apoptosis when stimulated by a variety of
agents [2], it is not known whether their normal
differentiation programme uses any components of the
apoptotic biochemical machinery to produce the
cornified cell. Differentiating keratinocytes have been
reported to share some features with apoptotic cells,
such as DNA fragmentation, but these features have not
been seen consistently [3]. Apoptosis involves an
intracellular proteolytic cascade, mainly mediated by
members of the caspase family of cysteine proteases,
which cleave one another and various key intracellular
target proteins to kill the cell neatly and quickly [4].
Here, we show for the first time that caspases are
activated during normal human keratinocyte
differentiation and that this activation is apparently
required for the normal loss of the nucleus.
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Results and discussion
At least five caspases, including caspase-3, are expressed in
human keratinocytes [5]. To determine whether caspase-3
becomes activated during human keratinocyte differentia-
tion, we used affinity-purified CM1 rabbit antibodies that
specifically recognize the cleaved, activated form of
caspase-3 but not uncleaved procaspase-3 [6]. When used
to immunostain newborn human foreskin, the antibodies
reproducibly stained patches of cells at the transition zone
between the granular and cornified layers of the epidermis
(Figure 1a,b), suggesting that procaspase-3 is activated late
during keratinocyte differentiation.
To investigate whether caspase activation is required for
normal keratinocyte differentiation, we used a culture
system in which newborn human foreskin keratinocytes
are grown on a matrix of denatured human dermis at an
air–liquid interface to generate a remarkably normal
looking epidermis [7,8]. This reconstituted epidermis
stained similarly to normal foreskin with the CM1 anti-
bodies (Figure 1c,d). Treatment of such cultures with
either of two cell-permeable peptide caspase inhibitors,
benzyloxycarboxyl-Val-Ala-Asp(O-methyl)-fluoromethyl-
ketone (zVAD-fmk) or Boc-Asp(O-methyl)-fluoromethyl-
ketone (BocD-fmk), consistently perturbed epidermal
development. When frozen sections of inhibitor-treated
Figure 1
CM1 antibody staining of (a,b) the epidermis of normal human foreskin
and (c,d) reconstituted epidermis. Confocal fluorescence (a,c) and
phase-contrast (b,d) micrographs of the same two fields. The sections
were stained with propidium iodide to visualize the nuclei (red) and
with CM1 antibodies to detect activated caspase-3 (green). CM1
labelling is detected in the region where nuclei are being lost. The
white lines represent the boundaries of the epidermis. Note that the
dermis underlying the reconstituted epidermis (c,d) has been treated in
a way that destroys the nuclei. CL, cornified layers; GL + SL, granular
and spinous layers; BL, basal layer; D, dermis. The scale bar
represents 20 µm.
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reconstituted epidermis were stained with propidium
iodide to visualize cell nuclei, the reconstituted epidermis
was usually of normal thickness, but in most regions the
cell nuclei failed to flatten and were maintained in the
most superficial epidermal layers (Figure 2c,d). By con-
trast, reconstituted epidermis developed normally in
untreated cultures (data not shown) and in cultures treated
with an inhibitor of the non-caspase protease cathepsin-B
— benzyloxycarboxyl-Phe-Ala(O-methyl)-fluoromethyl-
ketone (zFA-fmk) (Figure 2a,b). The caspase inhibitors
did not block all aspects of differentiation, however, as
keratinocytes still became flattened in the upper layers 
of reconstituted epidermis treated with zVAD-fmk or
BocD-fmk. These results suggest that caspase activation is
required for some aspects of keratinocyte differentiation,
such as nuclear loss, but not for others.
Nucleated keratinocytes are often seen in the cornified
layers of the epidermis under conditions in which the ker-
atinocytes proliferate excessively. To determine whether
the caspase inhibitors influence cell proliferation, we used
Ki67 antibodies to stain proliferating cells in frozen sections
of reconstituted epidermis [8]. In three separate experi-
ments the proportions of proliferating cells were 17 ± 4%
(mean ± standard deviation) in untreated cultures, 17 ± 1%
in cultures treated with the caspase inhibitor BocD-fmk,
and 19 ± 5% in cultures treated with the cathepsin-B
inhibitor zFA-fmk. Moreover, in all of these conditions,
Ki67-labelled cells were confined to the basal layer (data not
shown). Thus, neither the proportion of proliferating cells
nor their location was affected by the caspase inhibitors.
To confirm that some caspases are activated during normal
epidermal differentiation, we made cytosolic extracts of
normal foreskin epidermis and tested their ability to cleave
the fluorogenic peptide caspase substrate z-Asp-Glu-Val-
Asp-aminotrifluoromethylcoumarin (zDEVD-AFC), as pre-
viously described [9]. This peptide is efficiently cleaved
by caspase-3 and its close relatives [4]. In extracts of the
two samples of foreskin epidermis tested, we detected
cleavage activity that was comparable to that detected in
an extract of freshly dissociated rat thymocytes, where 5%
of the cells were apoptotic (as determined by propidium
iodide staining). When expressed in picomoles of
zDEVD-AFC per hour per µg protein [9], one epidermis
sample had a specific activity of 6.5, the other of 10.6, and
the thymocytes had a specific activity of 6.9. These find-
ings are consistent with the staining pattern seen with the
CM1 antibodies in Figure 1a and the conclusion that
caspase-3 (and/or related caspases) is activated during
normal keratinocyte differentiation.
We also used CM1 antibodies to probe western blots of
extracts of cultured keratinocytes and foreskin epidermis.
When we studied keratinocyte and foreskin extracts, the
CM1 antibodies revealed a faint doublet of around 25 kDa
(Figure 3a), but as expected [6], did not recognize any
bands of the size expected for procaspase-3 (30 kDa)
(Figure 3a). It is likely that the doublet represents cleaved
caspase-3, as it was greatly enhanced in keratinocytes that
had been induced to undergo apoptosis by treatment with
5 µM staurosporine and 10 µg/ml cycloheximide [10]. In
addition, the doublet levels were reduced when the
staurosporine- and cycloheximide-treated keratinocytes
were pretreated with BocD-fmk (Figure 3a). When we
induced keratinocytes to differentiate and form squames
at an air–liquid interface, the CM1 antibodies again
detected a similar doublet, the intensity of which was
reduced in cultures treated with BocD-fmk (Figure 3b).
The BocD-fmk treatment did not affect the levels of pro-
caspase-3 (Figure 3b). Taken together, these findings
support the conclusion that at least one caspase is cleaved
during keratinocyte differentiation.
To assess the effects of the caspase inhibitors on another
aspect of keratinocyte differentiation, we stained frozen
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Figure 2
Effects of treatment with a caspase inhibitor on epidermis development
in culture. (a,c) Confocal fluorescence and (b,d) phase-contrast
micrographs of reconstituted epidermis that had developed for
2 weeks in the presence of the control cathepsin-B inhibitor peptide
zFA-fmk (a,b) or the caspase inhibitor peptide BocD-fmk (c,d). The
sections were stained with propidium iodide to visualize the nuclei.
Note that, in the presence of the caspase inhibitor, nuclei are found in
the most superficial layers of the epidermis. The same results were
obtained if the caspase inhibitor was added for only the last week of
the culture (data not shown). Although in this experiment the
reconstituted epidermis treated with the caspase inhibitor is thinner
than that treated with the control peptide, this is not a consistent
finding (see Figure 4c–f). The scale bar represents 20 µm.
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sections of reconstituted epidermis with a monoclonal
antibody that recognizes the intermediate-filament-asso-
ciated protein filaggrin and its large precursor, profilag-
grin, which normally accumulates in keratohyalin granules
in the granular layer of the epidermis (reviewed in [1]). In
the upper regions of the granular layer, the profilaggrin is
cleaved into smaller filaggrin molecules, which decorate
the surface of the keratin filaments, causing the filaments
to aggregate [1] and giving the filaggrin staining a fibrillar
appearance (Figure 4a). Profilaggrin cleavage precedes
nuclear degradation [11], and it plays an important part in
the reorganization of the cytoskeleton that accompanies
the formation of the cornified envelope [1]. The pattern
of anti-filaggrin staining was similar in normal foreskin
epidermis and reconstituted epidermis that had devel-
oped in the presence of the cathepsin-B inhibitor 
zFA-fmk (compare Figure 4a with 4c). It was distinctly
different, however, in reconstituted epidermis that had
developed in the presence of caspase inhibitors: in this
case the filaggrin staining was greatly reduced and exclu-
sively granular (Figure 4e). It is possible, therefore, that
caspases may be required, either directly or indirectly, for
profilaggrin processing.
In summary, our findings suggest that keratinocyte differ-
entiation is accompanied by the activation of procaspase-3
and that the activation of at least one caspase is required for
both nuclear loss and normal filaggrin processing. It remains
to be determined which caspases are required for these
aspects of keratinocyte differentiation. The terminal differ-
entiation of a keratinocyte is not simply apoptosis, however,
because the outcome is very different from that of classical
apoptosis, where the cell usually shrinks, frequently frag-
ments, and is rapidly phagocytosed and digested [3,12,13].
It has been shown recently that caspases are also involved
in lens cell differentiation [14]: some caspases become
activated when rodent lens epithelial cells terminally dif-
ferentiate into anucleate lens fibers in vivo, and a caspase
inhibitor blocks the denucleation process in vitro. In addi-
tion, in Drosophila oogenesis, an inactivating mutation in a
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Figure 4
Effects on filaggrin expression of treatment with a caspase inhibitor.
(a,c,e) Confocal fluorescence and (b,d,f) phase-contrast micrographs
of normal foreskin (a,b), reconstituted epidermis that had developed in
the presence of the cathepsin-B inhibitor zFA-fmk (c,d), and
reconstituted epidermis that had developed in the presence of the
caspase inhibitor BocD-fmk (e,f). Note that the filaggrin staining
(green) is decreased and more granular in the BocD-treated samples
(e) compared to the staining in the other two preparations (a,c). The
scale bar represents 20 µm.
(a) (b)
(c) (d)
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Figure 3
Western blot analyses with CM1 antibodies on extracts of (a) cultured
keratinocytes and foreskin epidermis, or (b) reconstituted epidermis.
The same amount of protein was loaded in each lane. In (a), the CM1
antibodies detect a doublet of around 25 kDa in submerged cultures of
keratinocytes that had been induced to undergo apoptosis by
treatment with staurosporine and cycloheximide (denoted ‘STS’).
These bands are barely detectable in untreated keratinocytes, and they
are greatly reduced in keratinocytes treated with staurosporine and
cycloheximide but in the presence of the caspase inhibitor BocD-fmk.
The doublet is also weakly detected in foreskin epidermis. Anti-
procaspase-3 antibodies recognized a single band of around 30 kDa in
keratinocyte cultures. In (b), a similar doublet is seen in reconstituted
epidermis, but it is reduced in reconstituted epidermis that had
developed in the presence of BocD-fmk. The same blot in (b) was
reprobed with anti-procaspase-3 and anti-actin antibodies. Molecular
weight markers are indicated on the left.
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caspase gene prevents the cytoskeletal reorganization and
nuclear breakdown that normally occurs when nurse cells
transfer their cytoplasmic contents into a developing
oocyte [15]. Thus, there is increasing evidence that cas-
pases are involved in those differentiation processes that
are associated with organelle loss. The results of caspase
activation in these circumstances are clearly different from
classical apoptosis. The challenge now is to understand
the molecular bases of these differences.
Materials and methods
Keratinocyte culture
Normal human keratinocytes were isolated from neonatal foreskin epi-
dermis (strain kb, passage 4) and cultured on a feeder layer of J2-3T3
cells in FAD medium as described previously [16]. Reconstituted epi-
dermis was produced by culturing the keratinocytes on de-epidermized
human dermis (DED; prepared from normal adult abdominal skin) with
some modifications [8]. Cells were cultured submerged for a week,
and then raised to an air–liquid interface to promote keratinocyte termi-
nal differentiation for another week. In some experiments, a peptide
caspase inhibitor, zVAD-fmk or BocD-fmk, or the cathepsin-B inhibitor
zFA-fmk was added the day after seeding (final concentration 200 µM)
and again with every medium change for 2 weeks.
Immunohistochemistry
Affinity-purified CM1 rabbit antibodies (kindly supplied by Anu Srini-
vasan, Idun Pharmaceuticals) were raised against, and purified on, a 13
amino-acid peptide corresponding to the carboxyl terminus of the large
(p20) subunit of activated human caspase-3 [6]. The mouse mono-
clonal anti-human filaggrin antibody was purchased from Biomedical
Technologies. Normal human foreskin (from 11 or 39 day old infants) or
reconstituted epidermis were fixed in 4% paraformaldehyde and
stained by indirect immunofluorescence. All sections were double-
labeled with propidium iodide (1 µg/ml) to visualize the nuclei. The
stained sections were examined in an MRC-1000 laser-scanning fluo-
rescence confocal microscope. About six consecutive 1 µm optical
sections were summed to give a single fluorescence image, and a
transmitted-light confocal image of the same field was then recorded. 
Cytosolic extracts, caspase activity and western blots
Extracts of foreskin epidermis were prepared and assayed for enzy-
matic activity as previously described, using zDEVD-AFC (Enzyme
Systems Products) as substrate [9].
Supplementary material
Additional methodological details are published with this paper on
the internet.
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Supplementary materials and methods
Immunohistochemistry
Specimens were fixed in 4% paraformaldehyde in 0.1 M phosphate
buffer pH 7.4 for up to a day. The tissue was then incubated in 1 M
sucrose in the same buffer at 4°C overnight, embedded in OCT/1 M
sucrose solution (1:1, v:v) for at least 6 h with gentle shaking at room
temperature, snap-frozen in liquid nitrogen, and stored at –20°C. For
filaggrin staining, the tissue was left unfixed and treated as follows: 1 M
sucrose for 2 h at 4°C, frozen at –20°C, thawed at 4°C, and then
embedded in OCT/sucrose solution as above. Frozen tissue was cut
into 8 µm sections on a cryostat. Unfixed sections were fixed in methanol
for 10 min. All sections were incubated for 1 h in blocking buffer (10%
normal goat serum (NGS), 0.4% Triton X-100 in phosphate-buffered
saline (PBS)) at room temperature and then for 1 h in antibodies diluted
in incubation buffer (2% NGS, 0.4% Triton X-100 in PBS). The sections
were washed three times with 0.1% Tween 20 in PBS, and the bound
CM1 antibodies were detected with biotinylated anti-rabbit immunoglob-
ulin antibodies (Amersham), followed by streptavidin–FITC (Amersham).
The anti-filaggrin antibodies were detected with Cy5-conjugated goat
anti-mouse antibodies (Jackson Laboratories). The stained sections were
examined using an MRC-1000 laser-scanning fluorescence confocal
microscope. About six consecutive 1 µm optical sections were summed
to give a single fluorescence-image, and a transmitted-light confocal
image of the same field was then recorded.
Western blot assays
The foreskin epidermis and reconstituted epidermis were removed from
the dermis and DED, respectively, by treatment with 2.5 mg/ml dispase
(Boehringer Mannheim) as described previously [S1]. Confluent cul-
tures of human foreskin keratinocytes were treated for 5 h with 5 µM
staurosporine and 10 µg/ml cycloheximide, with or without 200 µM
BocD-fmk, or in medium alone. The epidermis or cultured keratinocytes
were dissolved in SDS–PAGE sample buffer containing β-mercap-
toethanol. Protein concentrations were measured in microtiter plates
using a Coomassie plus or BCA protein assay kit (Pierce), and the
samples were stored at –80°C. The samples (100 µg each) and molec-
ular weight markers were run on 15% SDS–PAGE gels and trans-
ferred to PVDF membranes using a semi-dry transfer apparatus
(Hoeffer Transblot). Western blotting was performed using the CM1
antibodies, the affinity-purified rabbit antibodies against procaspase-3
[S2], and the mouse monoclonal anti-actin antibody (ICN) as loading
control. The blots were developed using the Pierce Chemilumines-
cence substrate according to the manufacturer’s instructions.
Cytosolic extracts
Foreskin epidermis (isolated as above) was rinsed in cold PBS, quickly
blotted in tissue paper and transfered immediately into ice-cold buffer A
(20 mM Hepes–KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM Na
EDTA, 1 mM Na EGTA, 1 mM dithiothreitol), supplemented with pro-
tease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 5 µg/ml pepstatin
A, 10 µg/ml leupeptin, 2 µg/ml aprotinin, and 25 µg/ml n-acetyl-Leu-Leu-
norleucinal). The tissue was chopped into smaller pieces in this buffer,
and cytosolic extracts were prepared as previously described [S3].
Caspase activity
To detect the activity of caspase-3 and closely related caspases,
5–10 µg of thymocyte or 50 µg of foreskin epidermis extract were incu-
bated with the substrate zDEVD-AFC (Enzyme Systems Products) as
described previously [S3]. The amount of cleaved zDEVD-AFC in each
of three aliquots from each sample was measured (Perkin Elmer LS
50B; excitation at 400 nm and emission at 505 nm), and the specific
activity of caspases was calculated [S3].
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